Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | -2.10% | -11.39% | -25.53% |
15/05 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
14/05 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.53% | 94.21M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- Morgan Stanley Adjusts IO Biotech's Price Target to $15 from $21, Keeps Overweight Rating